Global Cardiovascular Devices Pipeline Landscape: Analysis of Key Upcoming Products and Technologies

1 Table of contents
1 Table of contents 3
1.1 List of Tables 5
1.2 List of Figures 6
2 Global Cardiovascular Devices Market Overview 7
2.1 Cardiovascular Devices, Global, Revenue ($m), Historic, 2000-2009 7
2.2 Cardiovascular Devices, Global, Revenue ($m), Forecast, 2009-2016 8
2.3 Global Cardiovascular Devices Market: Company Shares 9
3 Cardiac Rhythm Management : Pipeline Landscape 11
3.1 Cardiac Rhythm Management: Market Overview 11
3.1.1 Cardiac Rhythm Management, Global, Revenue ($m), Historic, 2000-2009 11
3.1.2 Cardiac Rhythm Management, Global, Revenue ($m), Forecast, 2009-2016 12
3.2 Cardiac Rhythm Management: Market Dynamics 13
3.2.1 Market Drivers 13
3.2.2 Market Restraints 13
3.3 Cardiac Rhythm Management: Technology Landscape 14
3.3.1 MRI Compatible Cardiac Rhythm Management Devices 14
3.3.2 EnRhythm MRI SureScan Pacing System 14
3.3.3 Wireless Cardiac Stimulation Device 18
3.3.4 Paradym sonR CRT- D 19
3.4 Cardiac Rhythm Management Pipeline Product Summary 22
4 Cardiovascular Monitoring and Diagnostic Devices: Pipeline Landscape 24
4.1 Cardiovascular Monitoring and Diagnostic Devices: Market Overview 24
4.1.1 Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), Historic,
2000-2009 24
4.1.2 Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), Forecast, 2009-2016 25
4.2 Cardiovascular Monitoring and Diagnostic Devices: Market Dynamics 26
4.2.1 Market Drivers 26
4.3 Cardiovascular Monitoring and Diagnostic Devices: Technology Landscape 26
4.3.1 Leadless Cardiac Monitoring Device 26
4.4 Cardiovascular Monitoring and Diagnostic Devices Pipeline Product Summary 28
5 Cardiovascular Prosthetic Devices: Pipeline Landscape 31
5.1 Cardiovascular Prosthetic Devices: Market Overview 31
5.1.1 Cardiovascular Prosthetic Devices, Global, Revenue ($ m), Historic, 2000-2009 31
5.1.2 Cardiovascular Prosthetic Devices, Global, Revenue ($ m), Forecast, 2009-2016 32
5.2 Cardiovascular Prosthetic Devices: Market Dynamics 33
5.2.1 Market Drivers 33
5.2.2 Market Restraints 34
5.3 Cardiovascular Prosthetic Devices: Technology Landscape 34
5.3.1 AbioCor II 34
5.3.2 3f Enable Aortic Valve 36
5.3.3 Perceval S Sutureless Aortic Valve 38
5.3.4 SAPIEN Transcatheter Heart Valve 40
5.3.5 Melody Transcatheter Pulmonary Valve 43
5.4 Cardiovascular Prosthetic Devices Pipeline Product Summary 48
6 Cardiovascular Surgery: Pipeline Landscape 53
6.1 Cardiovascular Surgery: Market Overview 53
6.1.1 Cardiovascular Surgery, Global, Revenue ($ m), Historic, 2000-2009 53
6.1.2 Cardiovascular Surgery, Global, Revenue ($ m), Forecast, 2009-2016 54
6.2 Cardiovascular Surgery: Market Dynamics 55
6.2.1 Market Drivers 55
6.2.2 Market Restraints 55
6.3 Cardiovascular Surgery: Technology Landscape 56
6.3.1 CyberHeart System 56
6.4 Cardiovascular Surgery Pipeline Product Summary 57
7 Electrophysiology: Pipeline Landscape 59
7.1 Electrophysiology: Market Overview 59
7.1.1 Electrophysiology, Global, Revenue ($ m), Historic, 2000-2009 59
7.1.2 Electrophysiology, Global, Revenue ($ m), Forecast, 2009-2016 60
7.2 Electrophysiology: Market Dynamics 61
7.2.1 Market Drivers 61
7.2.2 Market Restraints 61
7.3 Electrophysiology: Technology Landscape 61
7.3.1 Sensei System for Atrial Fibrillation 61
7.4 Electrophysiology Pipeline Product Summary 64
8 Interventional Cardiology: Pipeline Landscape 66
8.1 Interventional Cardiology: Market Overview 66
8.1.1 Interventional Cardiology, Global, Revenue ($ m), Historic, 2000-2009 66
8.1.2 Interventional Cardiology, Global, Revenue ($ m), Forecast, 2009-2016 67
8.2 Interventional Cardiology: Market Dynamics 68
8.2.1 Market Drivers 68
8.2.2 Market Restraints 69
8.3 Interventional Cardiology: Technology Landscape 69
8.3.1 Bioabsorbable stents 69
8.3.2 VestaSync 72
8.3.3 Combo Bio-engineered Sirolimus Eluting Stent 74
8.3.4 Intravascular Ultrasound 76
8.3.5 AMPLATZER PFO Occluder – Migraine 78
8.4 Interventional Cardiology Pipeline Product Summary 81
9 Peripheral Vascular Devices: Pipeline Landscape 91
9.1 Peripheral Vascular Devices: Market Overview 91
9.1.1 Peripheral Vascular Devices, Global, Revenue ($ m), Historic, 2000-2009 91
9.1.2 Peripheral Vascular Devices, Global, Revenue ($ m), Forecast, 2009-2016 93
9.2 Peripheral Vascular Devices: Market Dynamics 94
9.2.1 Market Drivers 94
9.2.2 Market Restraints 94
9.3 Peripheral Vascular Devices: Technology Landscape 94
9.3.1 ZILVER PTX Drug Eluting Peripheral Stent 94
9.4 Peripheral Vascular Devices Pipeline Product Summary 97
10 Appendix 102
10.1 Abbreviations 102
10.2 Definitions 103
10.2.1 Cardiovascular Devices 103
10.2.2 Cardiac Rhythm Management 103
10.2.3 Cardiovascular Monitoring and Diagnostic Devices 104
10.2.4 Cardiovascular Prosthetic Device 104
10.2.5 Cardiovascular Surgery 105
10.2.6 Electrophysiology 106
10.2.7 Interventional Cardiology 106
10.2.8 Peripheral Vascular Devices 107
10.3 Research Methodology 108
10.4 Secondary Research 109
10.5 Primary Research 109
10.6 Models 110
10.7 Forecasts 110
10.8 Expert Panels 110
10.9 Consulting 110
10.10 Contact Us 111
10.11 Disclaimer 1111.1 List of Tables
Table 1: Cardiovascular Devices, Global, Revenue ($ m), 2000-2009 7
Table 2: Cardiovascular Devices, Global, Revenue ($ m), 2009-2016 9
Table 3: Global Cardiovascular Devices Market, Company Shares, Revenue ($ m), 2008 10
Table 4: Cardiac Rhythm Management, Global, Revenue ($m), 2000-2009 11
Table 5: Cardiac Rhythm Management, Global, Revenue ($m), 2009-2016 12
Table 6: Paradym sonR CRT defibrillator, Europe, Revenue ($ m), 2009-2016 20
Table 7: Global Cardiac Rhythm Management Pipeline Product Summary - I 22
Table 8: Global Cardiac Rhythm Management Pipeline Product Summary - II 23
Table 9: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2000-2009 24
Table 10: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2009-2016 25
Table 11: Global Cardiovascular Monitoring And Diagnostic Devices Pipeline Product Summary - I 28
Table 12: Global Cardiovascular Monitoring And Diagnostic Devices Pipeline Product Summary - II 29
Table 13: Global Cardiovascular Monitoring And Diagnostic Devices Pipeline Product Summary - III 30
Table 14: Cardiovascular Prosthetic Devices, Global, Revenue ($ m), 2000-2009 31
Table 15: Cardiovascular Prosthetic Devices , Global, Revenue ($ m), 2009-2016 32
Table 16: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - I 48
Table 17: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - II 49
Table 18: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - III 50
Table 19: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - IV 51
Table 20: Global Cardiovascular Prosthetic Devices Pipeline Product Summary - V 52
Table 21: Cardiovascular Surgery, Global, Revenue ($ m), 2000-2009 53
Table 22: Cardiovascular Surgery, Global, Revenue ($ m), 2009-2016 54
Table 23: Global Cardiovascular Surgery Pipeline Product Summary - I 57
Table 24: Global Cardiovascular Surgery Pipeline Product Summary - II 58
Table 25: Electrophysiology, Global, Revenue ($ m), 2000-2009 59
Table 26: Electrophysiology, Global, Revenue ($ m), 2009-2016 60
Table 27: Global Electrophysiology Pipeline Product Summary -I 64
Table 28: Global Electrophysiology Pipeline Product Summary -II 65
Table 29: Interventional Cardiology, Global, Revenue ($ m), 2000-2009 66
Table 30: Interventional Cardiology, Global, Revenue ($ m), 2009-2016 67
Table 31: Global Interventional Cardiology Pipeline Product Summary - I 81
Table 32: Global Interventional Cardiology Pipeline Product Summary - II 82
Table 33: Global Interventional Cardiology Pipeline Product Summary - III 83
Table 34: Global Interventional Cardiology Pipeline Product Summary - IV 84
Table 35: Global Interventional Cardiology Pipeline Product Summary - V 85
Table 36: Global Interventional Cardiology Pipeline Product Summary - VI 86
Table 37: Global Interventional Cardiology Pipeline Product Summary - VII 87
Table 38: Global Interventional Cardiology Pipeline Product Summary - VIII 88
Table 39: Global Interventional Cardiology Pipeline Product Summary - IX 89
Table 40: Global Interventional Cardiology Pipeline Product Summary - X 90
Table 41: Peripheral Vascular Devices, Global, Revenue ($ m), 2000-2009 92
Table 42: Peripheral Vascular Devices, Global, Revenue ($ m), 2009-2016 93
Table 43: Global Peripheral Vascular Devices Pipeline Product Summary - I 97
Table 44: Global Peripheral Vascular Devices Pipeline Product Summary - II 98
Table 45: Global Peripheral Vascular Devices Pipeline Product Summary - III 99
Table 46: Global Peripheral Vascular Devices Pipeline Product Summary - IV 100
Table 47: Global Peripheral Vascular Devices Pipeline Product Summary - V 1011.2 List of Figures
Figure 1: Cardiovascular Devices, Global, Revenue ($m), 2000-2009 7
Figure 2: Cardiovascular Devices, Global, Revenue ($m), 2009-2016 8
Figure 3: Global Cardiovascular Devices Market, Company Shares (%), 2008 9
Figure 4: Cardiac Rhythm Management, Global, Revenue ($m), 2000-2009 11
Figure 5: Cardiac Rhythm Management, Global, Revenue ($m), 2009-2016 12
Figure 6: EnRhythm MRI SureScan pacing system: Features and Benefit Analysis 16
Figure 7: Wireless Cardiac Stimulation Device: Features and Benefit Analysis 18
Figure 8: Paradym sonR CRT-D: Features and Benefit Analysis 20
Figure 9: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2000-2009 24
Figure 10: Cardiovascular Monitoring and Diagnostic Devices, Global, Revenue ($ m), 2009-2016 25
Figure 11: Leadless Cardiac Monitoring Device: Features and Benefit Analysis 27
Figure 12: Cardiovascular Prosthetic Devices, Global, Revenue ($ m), 2000-2009 31
Figure 13: Cardiovascular Prosthetic Devices , Global, Revenue ($ m), 2009-2016 32
Figure 14: AbioCor II: Features and Benefit Analysis 35
Figure 15: 3f Enable Aortic Valve: Features and Benefit Analysis 37
Figure 16: Perceval S Sutureless Aortic Valve: Features and Benefit Analysis 39
Figure 17: SAPIEN Transcatheter Heart Valve: Features and Benefit Analysis 41
Figure 18: Melody Transcatheter Pulmonary Valve: Features and Benefit Analysis 44
Figure 19: Cardiovascular Surgery, Global, Revenue ($ m), 2000-2009 53
Figure 20: Cardiovascular Surgery, Global, Revenue ($ m), 2009-2016 54
Figure 21: CyberHeart System: Features and Benefit Analysis 56
Figure 22: Electrophysiology, Global, Revenue ($ m), 2000-2009 59
Figure 23: Electrophysiology, Global, Revenue ($ m), 2009-2016 60
Figure 24: Sensei System for Atrial Fibrillation: Features and Benefit Analysis, 2010 62
Figure 25: Interventional Cardiology, Global, Revenue ($ m), 2000-2009 66
Figure 26: Interventional Cardiology, Global, Revenue ($ m), 2009-2016 67
Figure 27: Abbott Bioabsorbable Everolimus Eluting Coronary Stent: Features and Benefit Analysis, 2010 70
Figure 28: VestaSync: Features and Benefit Analysis, 2010 73
Figure 29: Combo Bio-engineered Sirolimus Eluting Stent: Features and Benefit Analysis, 2010 75
Figure 30: Comparison of Coronary Angiogram With Intra Vascular Ultrasound Image, 2010 77
Figure 31: Intra Vascular Ultrasound: Features and Benefit Analysis, 2010 78
Figure 32: AMPLATZER PFO Occluder-migraine: Features and Benefit Analysis, 2010 79
Figure 33: Peripheral Vascular Devices, Global, Revenue ($ m), 2000-2009 91
Figure 34: Peripheral Vascular Devices, Global, Revenue ($ m), 2009-2016 93
Figure 35: ZILVER PTX Drug Eluting Peripheral Stent: Features and Benefit Analysis, 2010 95
Figure 36: Methodology 109